About Jay Brammer
Form D filings for Metabolics Pharma in 2024 list Jay Brammer as director.
Form D filings also name Jay Brammer as a director at Enterin.
Jay Brammer first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Jay Brammer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jay Brammer works with at each company, as listed on that company's latest Form D.
Metabolics Pharma, Inc. · Form D, Sep 19, 2024
MK
Mark Kamp
Director
JD
John Dessouki
Executive officer and director
MF
Mark Finn
Director
BM
Barry Miller
Director
RL
Richard Larson
Chief Executive Officer and director
Enterin, Inc. · Form D, Dec 6, 2023
MZ
Michael Zasloff
Director
DM
David McCullough
Chief Executive Officer and director
BM
Barry Miller
Director
DM
Don Munoz
Director
KW
Katherine Wolf
Executive officer
RL
Richard Larson
Executive officer
RM
Roger Mills
Director
WK
William Kinney
Executive officer
RP
Richard Propper
Director
MF
Mark Finn
Director